Paul V. Maier, Director at International Stem Cell CORP (ISCO.OB), sold 20,000 shares at $1.39 ($28K) on 2011-03-25, disclosed to the SEC on 2011-03-25.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.41 | 10,000 | $14K | 50.4% |
| 2 | $1.39 | 10,000 | $14K | 49.6% |
| Total | $1.40 avg | 20,000 | $28K | 100% |
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |